Dual-encapsulated liposomal vitamin C increases comparative oral exposure in a randomised crossover study in healthy adults
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: This study characterised DELT, a rice-protein-associated dual-encapsulation vitamin C powder, and compared its in vitro properties and short-term pharmacokinetic profile with conventional liposomal and reference vitamin C formulations. Physicochemical characterisation included particle size, polydispersity, surface charge, morphology and solid-state analysis. Vitamin C content, operational encapsulation efficiency, in vitro release and accelerated stability were also evaluated. An exploratory, randomised, double-blind, three-treatment, three-period crossover study was conducted in 12 healthy adults following a single oral dose containing 350 mg vitamin C. Re-dispersed DELT had a mean hydrodynamic diameter of 210.0 ± 33.4 nm and a polydispersity index of 0.025. Measured vitamin C content was 71.3 ± 1.0% w/w, and operational encapsulation efficiency was 87.8%. In phosphate buffer at pH 6.8, DELT released 35.0 ± 3.5% of its vitamin C by 8 h, compared with 78.8 ± 4.6% for unformulated vitamin C. During 8 months of accelerated storage at 40 °C/65% relative humidity, vitamin C content changed from 71.23% to 71.17% w/w. In the clinical study, mean baseline-corrected maximum plasma concentrations were 16.90 ± 1.90 µg/mL for DELT, 9.92 ± 1.10 µg/mL for conventional liposomal vitamin C and 2.62 ± 0.76 µg/mL for reference vitamin C. Corresponding areas under the concentration–time curve up to the last measured time point were 126.32 ± 19.60, 68.11 ± 8.46 and 11.43 ± 2.60 µg·h/mL, respectively. Pairwise comparisons were statistically significant ( p < 0.0001). These exploratory findings demonstrate differences in formulation characteristics, release behaviour and measured short-term plasma exposure. Larger studies with longer sampling, validated analytical procedures and compositionally matched comparators are required to confirm the pharmacokinetic findings and investigate the contribution of individual formulation components. Trial registration : Clinical Trials Registry–India, CTRI/2025/12/098688.
Source: Scientific Reports
Authors: Nandu Bhaskar Andalattu Vijayan(Writing – original draft), Ajanya Saji(Writing – original draft), Sreya Erezhath Sarun(Writing – original draft), Sandeep Gopalakrishnan(Conceptualization, Methodology, Resources), Gaanappriya Mohan(Resources, Writing – review & editing), Kalpana Balakrishnan
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7236249393
